Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
7,8 USD | -0,26 % | -4,41 % | -7,58 % |
Resumen de negocios
Número de empleados: 162
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Gene Therapies
100,0
%
| 41 | 100,0 % | 250 | 100,0 % | +511,16 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 41 | 100,0 % | 250 | 100,0 % | +511,16 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 01/03/22 |
Robin Swartz
DFI | Director of Finance/CFO | 53 | 01/09/21 |
Michael Higgins
CHM | Chairman | 61 | 22/07/15 |
Todd Carter
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/11/18 |
Glenn Pierce
BRD | Director/Board Member | 68 | 05/01/17 |
James Geraghty
BRD | Director/Board Member | 69 | 01/01/14 |
Beth Shafer
PRN | Corporate Officer/Principal | - | 07/08/23 |
Human Resources Officer | - | 14/09/20 | |
General Counsel | - | 10/07/23 | |
Trista Morrison
HRO | Human Resources Officer | - | 19/09/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 09/05/23 |
James Geraghty
BRD | Director/Board Member | 69 | 01/01/14 |
Glenn Pierce
BRD | Director/Board Member | 68 | 05/01/17 |
Catherine Mackey
BRD | Director/Board Member | 68 | 15/08/22 |
Steven Hyman
BRD | Director/Board Member | 71 | 17/09/15 |
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 01/03/22 |
Grace Colón
BRD | Director/Board Member | 57 | 01/01/23 |
Nancy Vitale
BRD | Director/Board Member | - | 15/09/20 |
Michael Higgins
CHM | Chairman | 61 | 22/07/15 |
Jude Onyia
BRD | Director/Board Member | 60 | 21/02/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 393 628 | 45 197 482 ( 83,09 %) | 0 | 83,09 % |
Información de la empresa
Voyager Therapeutics, Inc.
75 Hayden Avenue
02421, Lexington
+857 259 5340
http://www.voyagertherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-7,58 % | 425 M | |
+23,13 % | 52,73 mil M | |
+37,49 % | 39 mil M | |
-8,73 % | 38,52 mil M | |
+28,09 % | 30,38 mil M | |
-12,26 % | 26,39 mil M | |
+10,57 % | 26,08 mil M | |
+45,05 % | 14,15 mil M | |
+32,23 % | 12,6 mil M | |
-6,56 % | 11,51 mil M |
- Bolsa de valores
- Acciones
- Acción VYGR
- Empresa Voyager Therapeutics, Inc.